These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7469203)

  • 1. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
    Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
    Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of nuclear DNA content of laryngeal carcinoma and determination of estrogen receptor (ER) level in laryngeal cancer cells].
    Lin S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990; 25(6):331-3, 382. PubMed ID: 2093343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytophotometric measurements of nuclear DNA content values in human breast lesions.
    Enchev VG; Dobreva PV
    Arch Geschwulstforsch; 1987; 57(1):31-7. PubMed ID: 3566463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of quantitative biological cell parameters in the handling of mammary carcinoma.
    Theve NO; Azavedo E; Blomstedt B; Wiking N; Auer GU
    Acta Chir Scand; 1982; 148(3):239-41. PubMed ID: 6291293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ploidy, proliferative activity and estrogen receptor content in human breast cancer.
    Raber MN; Barlogie B; Latreille J; Bedrossian C; Fritsche H; Blumenschein G
    Cytometry; 1982 Jul; 3(1):36-41. PubMed ID: 7117052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relation between estrogen receptors and the clinical morphological characteristics of primary breast cancer].
    Vishniakova VV; Ermilova VD; Murav'eva NI; Bassalyk LS
    Arkh Patol; 1981; 43(7):20-3. PubMed ID: 7271502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contents of nuclear Feulgen-DNA in carcinoma of the breast. Cytophotometric analysis].
    Ricevuti G; Barni S
    Arch Sci Med (Torino); 1983; 140(4):393-400. PubMed ID: 6201153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer.
    Nativ O; Umehara T; Colvard DS; Therneau TM; Farrow GM; Spelsberg TC; Lieber MM
    Eur Urol; 1997; 32(1):96-9. PubMed ID: 9266239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and significance of diploid-range epithelial populations in DNA aneuploid breast carcinomas using multi-parametric flow cytometry.
    Visscher DW; Sochacki P; Ottosen S; Wykes S; Crissman JD
    Anal Cell Pathol; 1995 Jun; 8(4):267-77. PubMed ID: 7577742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
    Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
    Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of DNA content using a flow cytometry method and steroid hormone receptors in breast cancer].
    Zubrikhina GN; Kuz'mina EV; Bassalyk LS; Murav'eva NI
    Vopr Onkol; 1989; 35(10):1179-86. PubMed ID: 2596061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA in situ sensitivity to denaturation as a marker of human breast tumors.
    Kunicka JE; Olszewski W; Rosen PP; Kimmel M; Melamed MR; Darzynkiewicz Z
    Cancer Res; 1989 Nov; 49(22):6347-51. PubMed ID: 2804980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The changes in nuclear DNA amounts in the development and progression of uterine cervical cancer determined by cytofluorometry].
    Harada K
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):759-68. PubMed ID: 3722955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assay of DNA content and estrogen receptor status in human breast cancer].
    Chen GJ; Shao YF; Shan Y
    Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.